PBS updates

Diflucan (Fluconazole)

fluconazole 50 mg capsule, 28 · ORAL · PBS code 1471K

STREAMLINED

What it costs

AU$4.91 PBS-determined price per 28 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

  • • First listed on the PBS: 1994-08-01.
  • • Repeats: 5.
  • • PBS program: GE.
Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cryptococcal meningitis


Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Cryptococcal meningitis


The treatment must be maintenance therapy; AND

Patient must be immunosuppressed; AND

Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Oropharyngeal candidiasis


Patient must be immunosuppressed.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Oropharyngeal candidiasis


The treatment must be for prophylaxis; AND

Patient must be immunosuppressed.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Oesophageal candidiasis


Patient must be immunosuppressed.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Fungal infection


The condition must be serious or life-threatening; AND

Must be treated by a health practitioner who is any of: (i) a medical practitioner, (ii) an authorised PBS prescriber who is not a medical practitioner, but who is: (a) sharing care of the patient with at least one medical practitioner; (b) intending to share care of the patient with a medical practitioner.

Sponsor: Pfizer Australia Pty Ltd ABN 50 008 422 348

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.